The Lancet Neurology in conversation with
Ein Podcast von The Lancet Group - Donnerstags
187 Folgen
-
Giuseppe Citerio on frailty and TBI
Vom: 19.1.2022 -
Alberto Costa on memantine in adolescents and young adults with Down syndrome
Vom: 20.12.2021 -
Olivier Rascol on amantadine for patients with movement disorders
Vom: 17.11.2021 -
Antonio Uccelli on stems cells for MS
Vom: 20.10.2021 -
Priya Palta on blood pressure control and cognitive decline
Vom: 15.9.2021 -
Adam Boxer on tau biomarkers
Vom: 18.8.2021 -
Irene Cortese on the difficulties of designing clinical trials
Vom: 21.7.2021 -
Doug Turnbull on mitochondrial diseases in adults
Vom: 16.6.2021 -
Geert Jan Biessels on predicting post-stroke cognitive impairment
Vom: 19.5.2021 -
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
Vom: 21.4.2021 -
Anne MacGregor on menstrual migraine
Vom: 17.3.2021 -
Peter Rothwell on asymptomatic carotid stenosis and stroke
Vom: 17.2.2021 -
Spinal cord injury and degenerative cervical myelopathy
Vom: 20.1.2021 -
Genetic risk factors for sCJD
Vom: 22.12.2020 -
Prednisone in short-term prevention of cluster headache
Vom: 24.11.2020 -
PET imaging of inflammation in neurological and psychiatric disorders
Vom: 21.10.2020 -
Neurological associations of COVID-19
Vom: 4.9.2020 -
Advances in understanding of Rett syndrome
Vom: 31.7.2020 -
Management of Parkinson's disease
Vom: 17.6.2020 -
Optimal time to treat Huntington's Disease
Vom: 26.5.2020
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.
